Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

MLA

Mitsuyasu, Ronald T., et al. “Phase 2 Gene Therapy Trial of an Anti-HIV Ribozyme in Autologous CD34+ Cells.” Nature Medicine, vol. 15, no. 3, Mar. 2009, pp. 285–92. EBSCOhost, https://doi.org/10.1038/nm.1932.

APA

Mitsuyasu, R. T., Merigan, T. C., Carr, A., Zack, J. A., Winters, M. A., Workman, C., Bloch, M., Lalezari, J., Becker, S., Thornton, L., Akil, B., Khanlou, H., Finlayson, R., McFarlane, R., Smith, D. E., Garsia, R., Ma, D., Law, M., Murray, J. M., … Cooper, D. A. (2009). Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nature Medicine, 15(3), 285–292. https://doi.org/10.1038/nm.1932

Chicago

Mitsuyasu, Ronald T, Thomas C Merigan, Andrew Carr, Jerome A Zack, Mark A Winters, Cassy Workman, Mark Bloch, et al. 2009. “Phase 2 Gene Therapy Trial of an Anti-HIV Ribozyme in Autologous CD34+ Cells.” Nature Medicine 15 (3): 285–92. doi:10.1038/nm.1932.